Glaukos Corporation (GKOS) key performance indicators and operating metrics (7 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Diluted Earnings per Share Non-GAAP | -0.18 USD_per_share | FY2026-Q1 |
| Gross Margin Non-GAAP | 84.00 percent | FY2026-Q1 |
| United States Glaucoma Franchise Net Sales | 93.5M | FY2026-Q1 |
| Glaucoma Net Sales | 129.3M | FY2026-Q1 |
| Selling, General and Administrative Expenses Non-GAAP | 92.2M | FY2026-Q1 |
| Corneal Health Franchise Net Sales | 24M | FY2025-Q4 |
| Loss From Operations Non-GAAP | 16.4M | FY2025-Q4 |
Back to GKOS overview · GKOS earnings · GKOS holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.